Now that small molecular-level deletions and subtle chromosomal rearrangements can be discovered using advanced cytogenetic techniques and microarrays, disorders whose causes had
not previously been known can have their basis identified. However, since most of these are not widely publicized, being individually rare, it has been difficult to identify patients with shared chromosomal abnormalities who share phenotypic features. A new database, known as DECIPHER, is now available to search for patients with like phenotypes and/or like chromosomal abnormalities. If you are the clinical geneticist who has a patient whose data is entered into this database, suggest three or more ways using this database can benefit your patient or your field in general.
Correct Answer:
Verified
View Answer
Unlock this answer now
Get Access to more Verified Answers free of charge
Q41: If an entire genome is fragmented and
Q41: Being able to do a BLAST search,
Q43: The whole-genome shotgun approach (WGS)was first used
Q43: The movement of genes from one species
Q48: How and why is the two-hybrid system
Q50: Under what circumstances is a metagenomic analysis
Q51: A genome sequence is considered to be
Q51: You are interested in sequencing the gene
Q54: Genome- wide expression patterns can be studied
Q55: Sequencing of DNA from a community of
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents